Oral vinorelbine in metastatic breast cancer

被引：0
|
作者：
PF Conte
S Giovannelli
机构：
[1] University Hospital,Division of Medical Oncology, Department of Oncology and Haematology
[2] University of Modena and Reggio Emilia,undefined
来源：
Breast Cancer Research | / 7卷 / Suppl 1期
关键词：
Neutropenia; Docetaxel; Trastuzumab; Metastatic Breast Cancer; Capecitabine;
D O I：
10.1186/bcr1229
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A phase I study of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Kalykaki, A.
    Agelaki, S.
    Kotsakis, A.
    Vamvakas, L.
    Bozionelou, V.
    Kalbakis, K.
    Androulakis, N.
    Georgoulias, V.
    Mavroudis, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer
    Carreca, Ignazio
    Bronte, Giuseppe
    Burgio, Marco
    Carreca, Annapaola
    Piazza, Dario
    Rizzo, Sergio
    Russo, Salvatore
    ANNALS OF ONCOLOGY, 2006, 17 : 159 - 159
  • [33] A PHASE II TRIAL OF ORAL VINORELBINE AND CAPECITABINE IN ANTHRACYCLINE PRETREATED PATIENTS WITH METASTATIC BREAST CANCER
    Finek, J.
    Holubec, L.
    Svoboda, T.
    Sefrhansova, L.
    Pavlikova, I.
    Votavova, M.
    Sediva, M.
    Filip, S.
    Kozevnikova, R.
    Kormunda, S.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4023 - 4023
  • [34] Treatment of metastatic breast cancer (MBC) with Vinorelbine and Docetaxel
    Savio, Giuseppina
    Leonardi, Vita
    Alu, Massimiliano
    Laudani, Agata
    Calabria, Caterina
    Scianna, Caterina
    Agostara, Biagio
    Ascoli, Maurizio
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 48
  • [35] TREATMENT OF METASTATIC BREAST CANCER WITH ALTERNATIVE VINORELBINE AND GEMCITABINE
    Bensalem, A.
    Merrouche, M.
    Ammari, A.
    Benmerzouk, A.
    Bouzid, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 45 - 45
  • [36] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Liang Huang
    Xiaojia Wang
    Liheng Zhou
    Lijun Di
    Hongyu Zheng
    Zefei Jiang
    Yongsheng Wang
    Xiangqun Song
    Jifeng Feng
    Shiying Yu
    Yunpeng Liu
    Hong Zheng
    Kunwei Shen
    Zhongsheng Tong
    Zhimin Shao
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 205 - 215
  • [37] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Huang, Liang
    Wang, Xiaojia
    Zhou, Liheng
    Di, Lijun
    Zheng, Hongyu
    Jiang, Zefei
    Wang, Yongsheng
    Song, Xiangqun
    Feng, Jifeng
    Yu, Shiying
    Liu, Yunpeng
    Zheng, Hong
    Shen, Kunwei
    Tong, Zhongsheng
    Shao, Zhimin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 205 - 215
  • [38] Clinical benefit of vinorelbine in patients with metastatic breast cancer
    Schwarzlose-Schwarck, S.
    Regierer, A. C.
    Weigel, A.
    Fischer, J.
    Possinger, K.
    Eucker, J.
    ONKOLOGIE, 2010, 33 : 55 - 56
  • [39] Trastuzumab and Vinorelbine combination in the treatment of metastatic breast cancer
    Bayo, J. L.
    Mayordomo, J. I.
    Rovira, P. Sanchez
    Gonzalez, E.
    Bueno, J. M. Garcia
    Ramos, M.
    Crespo, C.
    Illarramendi, J.
    Valerdi, J.
    Palomo, A. Garcia
    EJC SUPPLEMENTS, 2004, 2 (03): : 130 - 130
  • [40] Oral vinorelbine in the treatment of advanced breast cancer.
    Bartsch, R
    Pluschnig, U
    Wenzel, C
    Hussian, D
    Locker, GJ
    Mader, R
    Zielinski, CC
    Steger, GG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 33S - 33S
12345